Compare CASS & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CASS | ZVRA |
|---|---|---|
| Founded | 1906 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 571.1M | 478.0M |
| IPO Year | 1996 | 2015 |
| Metric | CASS | ZVRA |
|---|---|---|
| Price | $41.81 | $8.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $45.50 | $21.71 |
| AVG Volume (30 Days) | 88.2K | ★ 868.7K |
| Earning Date | 01-22-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | ★ 37.29 | N/A |
| EPS | ★ 2.31 | 0.54 |
| Revenue | ★ $222,318,000.00 | $84,388,000.00 |
| Revenue This Year | N/A | $333.25 |
| Revenue Next Year | $7.33 | $43.70 |
| P/E Ratio | $18.07 | ★ $15.59 |
| Revenue Growth | 7.50 | ★ 244.60 |
| 52 Week Low | $36.08 | $6.19 |
| 52 Week High | $47.00 | $13.16 |
| Indicator | CASS | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 49.99 | 54.47 |
| Support Level | $39.85 | $8.08 |
| Resistance Level | $42.01 | $8.86 |
| Average True Range (ATR) | 1.17 | 0.40 |
| MACD | -0.08 | 0.04 |
| Stochastic Oscillator | 62.70 | 81.38 |
Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment, which provides transportation, energy, telecommunication, and environmental invoice processing and payment services to large corporations.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.